0
Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Á߳⿩¼ºÀÇ ¿îµ¿¼öÇà½ÇÅÂ¿Í ¿îµ¿¼öÇà¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¿äÀÎ

A Study on Exercise Performance and Its Relating Factors in Middle-aged Women

¿©¼º°Ç°­°£È£ÇÐȸÁö 2010³â 16±Ç 4È£ p.348 ~ 359
KMID : 0606420100160040348
¿À¼ºÀç ( Oh Sung-Jae ) - ¼øõÇâ´ëÇб³

±èÁõÀÓ ( Kim Jeung-Im ) - ¼øõÇâ´ëÇб³ °£È£Çаú
俵¶õ ( Chae Young-Ran ) - °­¿ø´ëÇб³ °£È£Çаú

Abstract

Purpose: This study was done to identify practical exercise performance and to define the factors related to exercise performance in middle-aged women.

Methods: The researchers collected data from 206 middle-aged women, ages 40 to 59. The measurements used were a scale for degree of exercise performance, and self-efficacy scale, affect, perceived barriers and benefits related exercise, body-shape perception, and the youngest child¡¯s education stage. The data were analyzed with SPSS/WIN 17.0 and SAS program using t-test, ANOVA, and stepwise multiple regression.

Results: Exercise performance showed significant differences according to body-shape perception (F=5.45, p<.01), the youngest child¡¯s education stage (F=4.44, p<.05). Exercise performance had a significant strong positive relation with self-efficacy (r=.616), a moderate relation with self-rated health (r=.428) and with affect related exercise (r=.519), a mild relation with perceived benefits (r=.339) and with social support (r=.239), and a negative mild relation with perceived barriers (r=-.330) with 99% significance. Self-efficacy, affect, perceived barriers, and the youngest child¡¯s education stage explained 46.4% of a variance in exercise performance in middle-aged women. The factor most influencing was self-efficacy related exercise at 37.9% of the variance.

Conclusion: We can conclude that self-efficacy, affect, perceived barriers, and the youngest child¡¯s education stage should be considered as important factors for developing program of middle-aged women.
KeyWords
¿îµ¿, ÀÚ±âÈ¿´É°¨, Á¤¼­, ÀÚ³à, Á߳⿩¼º
Exercise, Self-efficacy, Affect, Children, Middle-aged, Women
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
 
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed